Namibia vs United States: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Namibia
83.0%
in 2025
United States
84.0%
in 2025
Namibia rank
104th
United States rank
102nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Namibia
- United States
How they compare
United States currently reports 84.0% against 83.0% in Namibia, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was United States ahead.
Namibia ranks 104th and United States ranks 102nd of 194 countries.
United States has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Namibia | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 93.0% | 93.0% | United States |
| 2010s | 35.0% | 92.6% | 57.6% | United States |
| 2020s | 80.7% | 83.3% | 2.7% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Namibia or United States?
- United States, at 84.0% against 83.0% in Namibia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Namibia and United States?
- 1.0%, with United States ahead.
- How many years of comparable data are there for Namibia and United States?
- 18 years are reported by both, from 2008 to 2025.
- How do Namibia and United States rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Namibia ranks 104th and United States ranks 102nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.